UK markets closed

Virpax Pharmaceuticals, Inc. (VRPX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.4247-0.0753 (-3.01%)
As of 10:47AM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-15,190
-15,190
-21,651
-12,056
-4,340
Stock-based compensation
544.77
544.77
745.034
974.234
1,474
Change in working capital
4,791
4,791
3,059
-3,399
1,328
Accounts payable
-
-
-
-686.776
1,341
Other working capital
-9,854
-9,854
-17,847
-14,543
-1,385
Other non-cash items
-
-
-
-
153.222
Net cash provided by operating activities
-9,854
-9,854
-17,847
-14,543
-1,385
Cash flows from financing activities
Debt repayment
-
-
0
-1,604
0
Common stock issued
-
-
0
58,020
1,377
Other financing activities
-
-
-
-5,186
-50.88
Net cash used provided by (used for) financing activities
-
-
0
51,330
1,398
Net change in cash
-9,854
-9,854
-17,847
36,787
13.26
Cash at beginning of period
18,995
18,995
36,842
54.796
41.536
Cash at end of period
9,142
9,142
18,995
36,842
54.796
Free cash flow
Operating cash flow
-9,854
-9,854
-17,847
-14,543
-1,385
Free cash flow
-9,854
-9,854
-17,847
-14,543
-1,385